1272.8000 -9.20 (-0.72%)
NSE Jan 09, 2026 15:31 PM
Volume: 87,882
 

1272.80
-0.72%
Prabhudas Lilladhar
RAINBOW's Q4FY25 consolidated EBITDA grew by 9% YoY (down 15% QoQ) to Rs1.15bn, but 5% below our estimates due to weaker occupancy. RAINBOW enjoys higher margins, strong FCF generation with net cash B/S, and healthy...
Number of FII/FPI investors decreased from 245 to 239 in Sep 2025 qtr
More from Rainbow Childrens Medicare Ltd.
Recommended